• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Worsening Heart Failure Events in HFpEF: Underlying Biology Not Treatment Location.

作者信息

Mentz Robert J, Rao Vishal N

机构信息

Duke Clinical Research Institute, Durham, North Carolina, USA.

Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

JACC Heart Fail. 2021 May;9(5):383-385. doi: 10.1016/j.jchf.2021.02.001. Epub 2021 Apr 7.

DOI:10.1016/j.jchf.2021.02.001
PMID:33839077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9941978/
Abstract
摘要

相似文献

1
Worsening Heart Failure Events in HFpEF: Underlying Biology Not Treatment Location.射血分数保留的心力衰竭（HFpEF）中的心衰事件恶化：潜在生物学因素而非治疗地点
JACC Heart Fail. 2021 May;9(5):383-385. doi: 10.1016/j.jchf.2021.02.001. Epub 2021 Apr 7.
2
Progress and prospects of Sacubitril/Valsartan: Based on heart failure with preserved ejection fraction.沙库巴曲缬沙坦的研究进展与展望：基于射血分数保留的心力衰竭
Biomed Pharmacother. 2022 Nov;155:113701. doi: 10.1016/j.biopha.2022.113701. Epub 2022 Sep 15.
3
Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF Trial.心力衰竭症状和体征、预后及治疗反应的负担：PARAGON-HF 试验。
JACC Heart Fail. 2021 May;9(5):386-397. doi: 10.1016/j.jchf.2021.01.011. Epub 2021 Mar 10.
4
Effect of Sacubitril/Valsartan on renal function in patients with chronic kidney disease and heart failure with preserved ejection fraction: A real-world 12-week study.沙库巴曲缬沙坦对射血分数保留的慢性肾脏病并心力衰竭患者肾功能的影响：一项真实世界的 12 周研究。
Eur J Pharmacol. 2022 Aug 5;928:175053. doi: 10.1016/j.ejphar.2022.175053. Epub 2022 Jun 14.
5
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.PARAGON-HF 研究中醛固酮受体拮抗剂的心血管和肾脏结局。
JACC Heart Fail. 2021 Jan;9(1):13-24. doi: 10.1016/j.jchf.2020.08.014. Epub 2020 Nov 11.
6
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.PARAGON-HF 试验中射血分数保留的心力衰竭患者的基线特征。
Circ Heart Fail. 2018 Jul;11(7):e004962. doi: 10.1161/CIRCHEARTFAILURE.118.004962.
7
The effects of sacubitril/valsartan on heart failure with preserved ejection fraction: a meta-analysis.沙库巴曲缬沙坦对射血分数保留心力衰竭的影响：一项荟萃分析。
Acta Cardiol. 2022 Aug;77(6):471-479. doi: 10.1080/00015385.2021.1963101. Epub 2021 Aug 11.
8
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.血管紧张素受体脑啡肽酶抑制剂治疗射血分数保留心力衰竭：PARAGON-HF 试验的原理和设计。
JACC Heart Fail. 2017 Jul;5(7):471-482. doi: 10.1016/j.jchf.2017.04.013. Epub 2017 Jun 26.
9
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-脑啡肽酶抑制剂在射血分数保留的心力衰竭中的应用。
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
10
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).沙库巴曲缬沙坦或依那普利治疗心力衰竭患者中与低血压发作相关的发生率、预测因素和结局：PARADIGM-HF 试验（血管紧张素受体脑啡肽酶抑制剂与血管紧张素转换酶抑制剂前瞻性比较，以确定对心力衰竭全球死亡率和发病率的影响）。
Circ Heart Fail. 2018 Apr;11(4):e004745. doi: 10.1161/CIRCHEARTFAILURE.117.004745.

引用本文的文献

1
Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry.美国心脏协会 Get With The Guidelines-Heart Failure 注册研究中的社区社会经济劣势与心力衰竭住院结局
Circ Heart Fail. 2022 Nov;15(11):e009353. doi: 10.1161/CIRCHEARTFAILURE.121.009353. Epub 2022 Nov 15.

本文引用的文献

1
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.射血分数保留的心力衰竭患者院外心力衰竭恶化事件：PARAGON-HF 试验。
JACC Heart Fail. 2021 May;9(5):374-382. doi: 10.1016/j.jchf.2021.01.014. Epub 2021 Apr 7.
2
One-Year Mortality After Intensification of Outpatient Diuretic Therapy.门诊利尿剂治疗强化治疗后的 1 年死亡率。
J Am Heart Assoc. 2020 Jul 21;9(14):e016010. doi: 10.1161/JAHA.119.016010. Epub 2020 Jul 14.
3
Outpatient Intravenous Diuretic Therapy for Heart Failure in the United States.美国门诊心力衰竭患者的静脉利尿治疗
J Am Coll Cardiol. 2019 Mar 12;73(9):1101-1103. doi: 10.1016/j.jacc.2018.12.034.
4
Outpatient Worsening Heart Failure as a Target for Therapy: A Review.门诊心力衰竭恶化作为治疗靶点：综述。
JAMA Cardiol. 2018 Mar 1;3(3):252-259. doi: 10.1001/jamacardio.2017.5250.